These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15378018)

  • 1. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2004 Nov; 23(52):8486-96. PubMed ID: 15378018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
    Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
    Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
    Lakka SS; Rajagopal R; Rajan MK; Mohan PM; Adachi Y; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Roth JA; Yung WK; Kyritsis AP; Rao JS
    Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.
    Mohan PM; Chintala SK; Mohanam S; Gladson CL; Kim ES; Gokaslan ZL; Lakka SS; Roth JA; Fang B; Sawaya R; Kyritsis AP; Rao JS
    Cancer Res; 1999 Jul; 59(14):3369-73. PubMed ID: 10416596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
    Krueger S; Haeckel C; Buehling F; Roessner A
    Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
    Adachi Y; Chandrasekar N; Kin Y; Lakka SS; Mohanam S; Yanamandra N; Mohan PM; Fuller GN; Fang B; Fueyo J; Dinh DH; Olivero WC; Tamiya T; Ohmoto T; Kyritsis AP; Rao JS
    Oncogene; 2002 Jan; 21(1):87-95. PubMed ID: 11791179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
    Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells.
    de Bock CE; Lin Z; Itoh T; Morris D; Murrell G; Wang Y
    FEBS J; 2005 Jul; 272(14):3572-82. PubMed ID: 16008557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.
    Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Mol Cancer Ther; 2006 Dec; 5(12):3197-208. PubMed ID: 17172424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Neuron Glia Biol; 2004 May; 1(2):165-76. PubMed ID: 16804563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
    Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma.
    Malla RR; Gopinath S; Gondi CS; Alapati K; Dinh DH; Gujrati M; Rao JS
    Cancer Gene Ther; 2011 Jun; 18(6):419-34. PubMed ID: 21394106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
    Mai J; Sameni M; Mikkelsen T; Sloane BF
    Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.